Lung Cancer Clinical Trial
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
Summary
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Eligibility Criteria
Inclusion Criteria:
Site Eligibility (as per SC self-report)
& Must be designated as an American College of Radiology (ACR) designated lung cancer screening site
Reports at least one year of lung cancer screening experience
Reports conducting at least 20 new initial screenings per month Site Coordinator (SC) Eligibility (as per SC self-report)
Employed as a full-time Site Coordinator at participating lung cancer screening site Patient Eligibility (as per self-report)
Between the ages of 50-80 years old
Seeking baseline or annual follow-up LDCT lung cancer screening
Have at least a 20 pack-year history of smoking
Currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days.
Must be reachable by telephone
Must be English or Spanish speaking due to the study materials being available in only these languages and limited available resources for translation.
Exclusion Criteria:
Patient (as per self-report)
NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks or, unstable/worsening angina).
Smokers who are receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 17 Locations for this study
Los Angeles California, 90033, United States More Info
Principal Investigator
Walnut Creek California, 94598, United States More Info
Principal Investigator
Crown Point Indiana, 46307, United States More Info
Des Moines Iowa, 50314, United States More Info
Scarborough Maine, 04074, United States
New York New York, 10065, United States More Info
Principal Investigator
How clear is this clinincal trial information?